These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1362772)

  • 1. [Contribution of proliferating cell nuclear antigen to prognostic evaluation of carcinomas of the maxillary sinus].
    Mikuni H; Fukuda S; Furuta Y; Takasu T; Nagahashi T; Inuyama Y
    Nihon Jibiinkoka Gakkai Kaiho; 1992 Dec; 95(12):1944-9. PubMed ID: 1362772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic implication of proliferative markers MIB-1 and PC10 in esophageal squamous cell carcinoma.
    Lam KY; Law SY; So MK; Fok M; Ma LT; Wong J
    Cancer; 1996 Jan; 77(1):7-13. PubMed ID: 8630942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
    Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
    Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of proliferating cell nuclear antigen (PCNA) and p 53 protein correlate with prognosis of patients with oral squamous cell carcinoma.
    Kurokawa H; Yamashita Y; Takeda S; Miura K; Murata T; Kajiyama M
    Fukuoka Igaku Zasshi; 1999 Jan; 90(1):6-13. PubMed ID: 10087668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
    Tanioka F; Hiroi M; Yamane T; Hara H
    Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of proliferative markers Ki-67 (MIB-1) and proliferating cell nuclear antigen (PC10) in transitional cell carcinoma of the renal pelvis.
    Cheville JC; Terrell RB; Cohen MB
    Mod Pathol; 1994 Sep; 7(7):794-800. PubMed ID: 7824516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferating nuclear antigen (PCNA) as a prognostic factor of squamous cell carcinoma of the oesophagus.
    Dabrowski A; Szumiło J; Brajerski G; Wallner G
    Ann Univ Mariae Curie Sklodowska Med; 2001; 56():59-67. PubMed ID: 11977365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [PCNA (proliferating cell nuclear antigen) expression in adenocarcinomas < 2 cm of the peripheral lung].
    Koshikawa T; Nakamura S; Kitoh K; Hayashi K; Suyama M; Kunishima K
    Rinsho Byori; 1993 Jun; Suppl 94():113-24. PubMed ID: 8103122
    [No Abstract]   [Full Text] [Related]  

  • 9. [Correlation of GST-pi and PCNA expression to prognosis of advanced maxillary sinus squamous cell carcinoma].
    Guo GF; Xie RH; Yang AK; Chen ZH; Wu QL; Liu WW; Ou SM; Xia LP; Chen MY; Zhang JX
    Ai Zheng; 2005 Oct; 24(10):1267-71. PubMed ID: 16219146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer.
    Siitonen SM; Kallioniemi OP; Isola JJ
    Am J Pathol; 1993 Apr; 142(4):1081-9. PubMed ID: 7682759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma].
    Reitmaier M; Rudlowski C; Biesterfeld S; Rath W; Schröder W
    Zentralbl Gynakol; 2000; 122(7):361-7. PubMed ID: 10951706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferating cell nuclear antigen immunostaining in breast cancer and its relation to prognosis.
    Narita T; Funahashi H; Satoh Y; Takagi H
    Jpn J Clin Oncol; 1993 Feb; 23(1):20-5. PubMed ID: 8096256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients.
    Ishida T; Kaneko S; Akazawa K; Tateishi M; Sugio K; Sugimachi K
    Cancer Res; 1993 Oct; 53(20):5000-3. PubMed ID: 8104690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Measurement of PCNA labeling index in astrocytic tumors].
    Beppu T; Arai H; Kanaya H; Sasaki K
    No Shinkei Geka; 1992 Dec; 20(12):1255-9. PubMed ID: 1362456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal breast cancer: analysis of proliferative activity using a monoclonal antibody to proliferating cell nuclear antigen (PCNA) and its relationship to histological grade and prognosis.
    Lanzafame S; Magro G; Broggi B
    Pathologica; 1994 Apr; 86(2):150-6. PubMed ID: 7936757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinoma breast.
    Aziz SA; Pervez S; Khan SM; Kayani N; Nasir MI
    J Coll Physicians Surg Pak; 2005 Apr; 15(4):225-9. PubMed ID: 15857596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen.
    Yu CC; Dublin EA; Camplejohn RS; Levison DA
    Anal Cell Pathol; 1995 Jul; 9(1):45-52. PubMed ID: 7577754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of immunohistochemical staining for proliferating cell nuclear antigen, p53, and c-erbB-2 in sebaceous gland carcinoma and sweat gland carcinoma: comparison with histopathological parameter.
    Hasebe T; Mukai K; Yamaguchi N; Ishihara K; Kaneko A; Takasaki Y; Shimosato Y
    Mod Pathol; 1994 Jan; 7(1):37-43. PubMed ID: 7909154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical analysis of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinomas: comparison with clinical and pathologic variables.
    Frierson HF
    Mod Pathol; 1993 May; 6(3):290-4. PubMed ID: 8102204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.